{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Inconduite professionnelle : Questions médicales les plus fréquentes",
"headline": "Inconduite professionnelle : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Inconduite professionnelle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-17",
"dateModified": "2025-03-14",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Inconduite professionnelle"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Éthique",
"url": "https://questionsmedicales.fr/mesh/D004989",
"about": {
"@type": "MedicalCondition",
"name": "Éthique",
"code": {
"@type": "MedicalCode",
"code": "D004989",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N05.350"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Inconduite scientifique",
"alternateName": "Scientific Misconduct",
"url": "https://questionsmedicales.fr/mesh/D015871",
"about": {
"@type": "MedicalCondition",
"name": "Inconduite scientifique",
"code": {
"@type": "MedicalCode",
"code": "D015871",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N05.350.979.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Inconduite professionnelle",
"alternateName": "Professional Misconduct",
"code": {
"@type": "MedicalCode",
"code": "D028743",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Charles Piller",
"url": "https://questionsmedicales.fr/author/Charles%20Piller",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Shokoh Varaei",
"url": "https://questionsmedicales.fr/author/Shokoh%20Varaei",
"affiliation": {
"@type": "Organization",
"name": "School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran."
}
},
{
"@type": "Person",
"name": "Nahid Dehghan Nayeri",
"url": "https://questionsmedicales.fr/author/Nahid%20Dehghan%20Nayeri",
"affiliation": {
"@type": "Organization",
"name": "Nursing and Midwifery Care Research Center, School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran."
}
},
{
"@type": "Person",
"name": "Leila Sayadi",
"url": "https://questionsmedicales.fr/author/Leila%20Sayadi",
"affiliation": {
"@type": "Organization",
"name": "School of nursing & midwifery, Nursing and Midwifery Care Research Center, Tehran University of Medical Sciences, Tehran, Iran."
}
},
{
"@type": "Person",
"name": "Akram Ghobadi",
"url": "https://questionsmedicales.fr/author/Akram%20Ghobadi",
"affiliation": {
"@type": "Organization",
"name": "School of Nursing and Midwifery, Kermanshah University of Medical Sciences, Kermanshah, Iran. ghobadi_a57@yahoo.com."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Baicalin prevents fibrosis of human trabecular meshwork cells via inhibiting the MyD88/NF-κB pathway.",
"datePublished": "2022-11-25",
"url": "https://questionsmedicales.fr/article/36442621",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejphar.2022.175425"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Delayed Turnover of Proteasome Processing of Myocilin upon Dexamethasone Stimulation Introduces the Profiling of Trabecular Meshwork Cells' Ubiquitylome.",
"datePublished": "2024-09-17",
"url": "https://questionsmedicales.fr/article/39337505",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms251810017"
}
},
{
"@type": "ScholarlyArticle",
"name": "The effect of ET1-CTGF mediated pathway on the accumulation of extracellular matrix in the trabecular meshwork and its contribution to the increase in IOP.",
"datePublished": "2023-05-09",
"url": "https://questionsmedicales.fr/article/37160587",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10792-023-02733-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Corneal endothelial cell loss after EX-PRESS surgery depends on site of insertion, cornea or trabecular meshwork.",
"datePublished": "2023-06-05",
"url": "https://questionsmedicales.fr/article/37273152",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10792-023-02752-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Fibrotic Response of Human Trabecular Meshwork Cells to Transforming Growth Factor-Beta 3 and Autotaxin in Aqueous Humor.",
"datePublished": "2022-09-03",
"url": "https://questionsmedicales.fr/article/36139071",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/biom12091231"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Qualité, accès, évaluation des soins de santé",
"item": "https://questionsmedicales.fr/mesh/D017530"
},
{
"@type": "ListItem",
"position": 3,
"name": "Éthique",
"item": "https://questionsmedicales.fr/mesh/D004989"
},
{
"@type": "ListItem",
"position": 4,
"name": "Inconduite professionnelle",
"item": "https://questionsmedicales.fr/mesh/D028743"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Inconduite professionnelle - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Inconduite professionnelle",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Inconduite professionnelle",
"description": "Comment identifier l'inconduite professionnelle ?\nQuels signes indiquent une inconduite ?\nQui peut signaler une inconduite ?\nQuels outils aident au diagnostic ?\nQuelles sont les conséquences d'un diagnostic tardif ?",
"url": "https://questionsmedicales.fr/mesh/D028743?mesh_terms=Trabecular+Meshwork&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Inconduite professionnelle",
"description": "Quels symptômes peuvent alerter sur une inconduite ?\nComment les patients réagissent-ils à l'inconduite ?\nQuels effets psychologiques l'inconduite a-t-elle ?\nY a-t-il des signes de stress chez le professionnel ?\nComment l'inconduite affecte-t-elle l'équipe médicale ?",
"url": "https://questionsmedicales.fr/mesh/D028743?mesh_terms=Trabecular+Meshwork&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Inconduite professionnelle",
"description": "Comment prévenir l'inconduite professionnelle ?\nQuel rôle joue la supervision dans la prévention ?\nComment impliquer les patients dans la prévention ?\nQuels outils technologiques aident à la prévention ?\nQuelle est l'importance de la culture organisationnelle ?",
"url": "https://questionsmedicales.fr/mesh/D028743?mesh_terms=Trabecular+Meshwork&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Inconduite professionnelle",
"description": "Quels traitements pour les victimes d'inconduite ?\nComment traiter l'inconduite chez un professionnel ?\nQuelles sanctions pour inconduite professionnelle ?\nComment réhabiliter un professionnel fautif ?\nQuels programmes de prévention existent ?",
"url": "https://questionsmedicales.fr/mesh/D028743?mesh_terms=Trabecular+Meshwork&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Inconduite professionnelle",
"description": "Quelles complications peuvent résulter de l'inconduite ?\nComment l'inconduite affecte-t-elle la réputation ?\nY a-t-il des conséquences légales ?\nComment l'inconduite impacte-t-elle le personnel ?\nQuelles sont les répercussions sur les patients ?",
"url": "https://questionsmedicales.fr/mesh/D028743?mesh_terms=Trabecular+Meshwork&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Inconduite professionnelle",
"description": "Quels facteurs augmentent le risque d'inconduite ?\nComment la formation influence-t-elle le risque ?\nQuel rôle joue l'environnement de travail ?\nLes antécédents personnels influencent-ils le risque ?\nComment la culture institutionnelle impacte-t-elle le risque ?",
"url": "https://questionsmedicales.fr/mesh/D028743?mesh_terms=Trabecular+Meshwork&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier l'inconduite professionnelle ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'inconduite se détecte par des plaintes, des comportements inappropriés ou des violations éthiques."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une inconduite ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des comportements tels que négligence, abus de pouvoir ou fraude peuvent indiquer une inconduite."
}
},
{
"@type": "Question",
"name": "Qui peut signaler une inconduite ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Tout membre du personnel médical, patient ou tiers peut signaler une inconduite professionnelle."
}
},
{
"@type": "Question",
"name": "Quels outils aident au diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des enquêtes, des audits et des évaluations de performance aident à diagnostiquer l'inconduite."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'un diagnostic tardif ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic tardif peut aggraver les dommages aux patients et compromettre la sécurité des soins."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent alerter sur une inconduite ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des plaintes répétées de patients, des erreurs fréquentes ou un comportement inapproprié sont des symptômes."
}
},
{
"@type": "Question",
"name": "Comment les patients réagissent-ils à l'inconduite ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients peuvent ressentir de la méfiance, de l'anxiété ou de la détresse face à l'inconduite."
}
},
{
"@type": "Question",
"name": "Quels effets psychologiques l'inconduite a-t-elle ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'inconduite peut entraîner des traumatismes psychologiques chez les patients affectés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes de stress chez le professionnel ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un professionnel en inconduite peut montrer des signes de stress, d'irritabilité ou d'isolement."
}
},
{
"@type": "Question",
"name": "Comment l'inconduite affecte-t-elle l'équipe médicale ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut créer des tensions, diminuer la confiance et affecter la collaboration au sein de l'équipe."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'inconduite professionnelle ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par des formations éthiques, des codes de conduite et un environnement de travail sain."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la supervision dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une supervision adéquate permet de détecter et de corriger les comportements inappropriés rapidement."
}
},
{
"@type": "Question",
"name": "Comment impliquer les patients dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients peuvent être formés à reconnaître et signaler des comportements inappropriés."
}
},
{
"@type": "Question",
"name": "Quels outils technologiques aident à la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des systèmes de signalement en ligne et des applications de suivi des comportements peuvent aider."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de la culture organisationnelle ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une culture organisationnelle positive favorise l'éthique et réduit les risques d'inconduite."
}
},
{
"@type": "Question",
"name": "Quels traitements pour les victimes d'inconduite ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les victimes peuvent bénéficier de thérapies psychologiques et de soutien émotionnel."
}
},
{
"@type": "Question",
"name": "Comment traiter l'inconduite chez un professionnel ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mesures disciplinaires, des formations et un suivi psychologique peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Quelles sanctions pour inconduite professionnelle ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les sanctions peuvent inclure des avertissements, des suspensions ou des radiations de l'ordre."
}
},
{
"@type": "Question",
"name": "Comment réhabiliter un professionnel fautif ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La réhabilitation peut passer par des formations, du mentorat et un suivi régulier."
}
},
{
"@type": "Question",
"name": "Quels programmes de prévention existent ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des programmes de formation éthique et de sensibilisation sont mis en place pour prévenir l'inconduite."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent résulter de l'inconduite ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des dommages physiques, psychologiques et une perte de confiance dans le système de santé."
}
},
{
"@type": "Question",
"name": "Comment l'inconduite affecte-t-elle la réputation ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'inconduite peut gravement nuire à la réputation du professionnel et de l'établissement de santé."
}
},
{
"@type": "Question",
"name": "Y a-t-il des conséquences légales ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'inconduite peut entraîner des poursuites judiciaires et des sanctions pénales."
}
},
{
"@type": "Question",
"name": "Comment l'inconduite impacte-t-elle le personnel ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut créer un environnement de travail toxique, affectant le moral et la productivité du personnel."
}
},
{
"@type": "Question",
"name": "Quelles sont les répercussions sur les patients ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients peuvent subir des erreurs médicales, des abus ou une détérioration de leur état de santé."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'inconduite ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress, la surcharge de travail et un manque de supervision sont des facteurs de risque importants."
}
},
{
"@type": "Question",
"name": "Comment la formation influence-t-elle le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une formation insuffisante peut accroître le risque d'inconduite en diminuant la sensibilisation éthique."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'environnement de travail ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un environnement de travail toxique ou compétitif peut favoriser l'inconduite professionnelle."
}
},
{
"@type": "Question",
"name": "Les antécédents personnels influencent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de comportements inappropriés ou de problèmes psychologiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Comment la culture institutionnelle impacte-t-elle le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une culture institutionnelle laxiste envers l'éthique peut accroître le risque d'inconduite."
}
}
]
}
]
}
Trabecular meshwork fibrosis contributes to increased aqueous humor outflow resistance, leading to elevated intraocular pressure in primary open-angle glaucoma. Baicalin, an extract from Scutellaria b...
Glaucoma is chronic optic neuropathy whose pathogenesis has been associated with the altered metabolism of Trabecular Meshwork Cells, which is a cell type involved in the synthesis and remodeling of t...
To investigate the effect of endothelin-1 (ET-1) in excessive accumulation of extracellular matrix (ECM) of the trabecular meshwork (TM) and its role in intraocular pressure (IOP) regulation....
Cultured human TM cells (HTMCs) were treated with ET-1, ET-1 + ETA receptor (ETAR) antagonist BQ123, ET-1 + ETB receptor (ETBR) antagonist BQ788. The expressions of fibronectin (FN) and collagen type ...
In cultured HTMCs, the expressions of FN and Col IV were significantly increased after ET-1 treatment, which were blocked by the pretreatment of ETAR antagonist BQ123, rather than ETBR antagonist BQ78...
Excessive ET-1 in aqueous humor could lead to the abnormal accumulation of FN and Col IV in TM via the ETA-CTGF pathway, thereby increasing IOP....
Previously, we reported that the Ex-press® shunt (EXP) was associated with more rapid reduction in corneal endothelial cells when inserted into the cornea rather than the trabecular meshwork (TM). We ...
This was a retrospective study. We included patients who had undergone EXP surgery and were followed for > 5 years. We analyzed the corneal endothelial cell density (ECD) before and after EXP implanta...
We included 25 patients in the corneal insertion group and 53 patients in the TM insertion group. One patient in the corneal insertion group developed bullous keratopathy. The ECD decreased significan...
Insertion into cornea is a risk factor for rapid ECD loss. The EXP should be inserted into the TM to preserve the corneal endothelial cells....
This study examines the potential role of transforming growth factor-beta 3 (TGF-β3) on the fibrotic response of cultured human trabecular meshwork (HTM) cells. The relationships and trans-signaling i...
Pseudoexfoliation glaucoma (XFG) is an aggressive form of secondary open angle glaucoma, characterised by the production of exfoliation material and is estimated to affect 30 million people worldwide....
The multifunctional profibrotic cytokine transforming growth factor-beta2 (TGF-β2) is implicated in the pathophysiology of primary open angle glaucoma. Paeoniflorin (PAE) is a monoterpene glycoside wi...
Primary or transformed (GTM3) human TM (HTM) cells conditioned in serum-free media were incubated with TGF-β2 (5 ng/mL). PAE (300 μM) was added to serum-starved confluent cultures of HTM cells for 2 h...
PAE attenuated TGF-β2-induced oxidative stress and suppressed TGF-β2-induced Smad2/3 signaling in primary or transformed HTM cells. Additionally, PAE repressed TGF-β2-induced upregulation of collagen ...
PAE alleviates TGF-β2-induced ECM deposition and oxidative stress in HTM cells through inactivation of Smad2/3 signaling....
A common adverse response to the clinical use of glucocorticoids (GCs) is elevated intraocular pressure (IOP) which is a major risk factor for glaucoma. Elevated IOP arises due to impaired outflow of ...
Intraocular pressure (IOP) is considered an important modifiable risk factor for glaucoma, which is known as the second leading cause of blindness worldwide. However, lowering the IOP is not always su...
We demonstrated whether the difference of trabecular meshwork remodeling occur depending on the incisional cross-sectional area by comparing Kahook dual-blade goniotomy (KDB) and ab interno trabeculot...